Filing Details
- Accession Number:
- 0000315066-22-001406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-11 10:40:00
- Reporting Period:
- 2022-02-09
- Accepted Time:
- 2022-02-11 10:40:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1840574 | Verve Therapeutics Inc. | VERV | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-02-09 | 13,190 | $29.46 | 829,694 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
Footnotes
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $29.25 to $29.78. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.